Escitalopram til behandling af smerter ved polyneuropatiEn dobbeltblind, randomiseret, placebokontrolleret undersøgelse(Escitalopram as a treatment for painful polyneuropathy: A double-blind, randomised, placebo-controlled trial.)

Dept. of Neurology, Odense University Hospital0 个研究点目标入组 50 人开始时间: 2004年12月2日最近更新: 2021年5月25日

适应症

试验速览

暂无简介。

•age over 20 and under 80 years
•characteristic symptoms of polyneuropathy within at least 6 months
•diagnosis confirmed by physical examination, neurophysiologic exam. and/or quantitative sensory testing
•median total pain score at baseline week >=4 on a 10 point numerical rating scale
•pain at least 4 of 7 days
•fertile women are using anticonception
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•other cause to pain than polyneuropathy
•former allergic reactions on escitalopram
•known adverse events on escitalopram
•pregnancy or nursing
•critical disease (terminal cancer, cardial incompensation or critical renal or lung disease)
•treatment with monoaminooxidase inhibitors between the trial or 2 weeks before or after
•treatment with other antidepressants, antiepilectic agents or opioids

发起方

Dept. of Neurology, Odense University Hospital